High Free Cash Flow Stocks
PGNY is currently part of our High Free Cash Flow Stocks screen, indicating it generates strong cash flows relative to its price.
PROGYNY INC (PGNY) Stock Price & Overview
NASDAQ:PGNY • US74340E1038
Current stock price
16.6 USD
-0.26 (-1.54%)
At close:
16.4 USD
-0.2 (-1.2%)
After Hours:
The current stock price of PGNY is 16.6 USD. Today PGNY is down by -1.54%. In the past month the price decreased by -5.79%. In the past year, price decreased by -26.55%.
PGNY Key Statistics
52-Week Range16.28 - 28.75
Current PGNY stock price positioned within its 52-week range.
1-Month Range16.28 - 18.6
Current PGNY stock price positioned within its 1-month range.
- Market Cap
- 1.36B
- P/E
- 25.54
- Fwd P/E
- 15.75
- EPS (TTM)
- 0.65
- Dividend Yield
- N/A
PGNY Stock Performance
Today
-1.54%
1 Week
-6.69%
1 Month
-5.79%
3 Months
-35.51%
Longer-term
6 Months -19.38%
1 Year -26.55%
2 Years -48.22%
3 Years -50.06%
5 Years -70.83%
10 Years N/A
PGNY Stock Chart
PGNY Stock Screens
PGNY currently appears in the following ChartMill screener lists.
RSI Oversold Stocks
PGNY is flagged as RSI oversold, meaning recent selling pressure has pushed momentum to extreme levels that may lead to a short-term rebound.
PGNY Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to PGNY. When comparing the yearly performance of all stocks, PGNY is a bad performer in the overall market: 90.17% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
PGNY Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to PGNY. PGNY has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
PGNY Earnings
On February 26, 2026 PGNY reported an EPS of 0.14 and a revenue of 318.40M. The company missed EPS expectations (-5.34% surprise) and beat revenue expectations (1.53% surprise).
Next Earnings DateMay 6, 2026
Last Earnings DateFeb 26, 2026
PeriodQ4 / 2025
EPS Reported$0.14
Revenue Reported318.403M
EPS Surprise -5.34%
Revenue Surprise 1.53%
PGNY Forecast & Estimates
17 analysts have analysed PGNY and the average price target is 28.1 USD. This implies a price increase of 69.26% is expected in the next year compared to the current price of 16.6.
For the next year, analysts expect an EPS growth of 62.1% and a revenue growth 7.67% for PGNY
Analysts
Analysts83.53
Price Target28.1 (69.28%)
EPS Next Y62.1%
Revenue Next Year7.67%
PGNY Groups
Sector & Classification
PGNY Financial Highlights
Over the last trailing twelve months PGNY reported a non-GAAP Earnings per Share(EPS) of 0.65. The EPS increased by 14.04% compared to the year before.
Income Statements
Revenue(TTM)1.29B
Net Income(TTM)58.52M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 4.54% | ||
| ROA | 7.88% | ||
| ROE | 11.34% | ||
| Debt/Equity | 0 |
Chartmill High Growth Momentum
EPS Q2Q%16.67%
Sales Q2Q%6.69%
EPS 1Y (TTM)14.04%
Revenue 1Y (TTM)10.4%
PGNY Ownership
Ownership
Inst Owners105.63%
Shares81.90M
Float80.39M
Ins Owners1.48%
Short Float %7.01%
Short Ratio3.56
PGNY Competitors/Peers
The largest stocks on the US markets in the "Managed Health Care" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| UNH | UNITEDHEALTH GROUP INC | 15.37 | 251.663B | ||
| ELV | ELEVANCE HEALTH INC | 11.5 | 66.373B | ||
| HUM | HUMANA INC | 19.21 | 21.349B | ||
| CNC | CENTENE CORP | 11.55 | 17.266B | ||
| HQY | HEALTHEQUITY INC | 18.44 | 7.234B | ||
| MOH | MOLINA HEALTHCARE INC | 17.92 | 7.178B | ||
| ALHC | ALIGNMENT HEALTHCARE INC | 42.04 | 3.833B | ||
| CLOV | CLOVER HEALTH INVESTMENTS CO | N/A | 902.432M |
Related stock screener links
View all stocks in the Managed Health Care Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find more growth stocks the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About PGNY
Company Profile
Progyny, Inc. is a fertility benefits management company. The company is headquartered in New York City, New York and currently employs 856 full-time employees. The company went IPO on 2019-10-25. The firm specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. The company has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The firm provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. The company provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
Company Info
IPO: 2019-10-25
PROGYNY INC
1359 Broadway, 2Nd Floor
New York City NEW YORK 10018 US
CEO: David Schlanger
Employees: 856
Phone: 18009279800
PROGYNY INC / PGNY FAQ
What does PGNY do?
Progyny, Inc. is a fertility benefits management company. The company is headquartered in New York City, New York and currently employs 856 full-time employees. The company went IPO on 2019-10-25. The firm specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. The company has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The firm provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. The company provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
What is the stock price of PROGYNY INC today?
The current stock price of PGNY is 16.6 USD. The price decreased by -1.54% in the last trading session.
What is the dividend status of PROGYNY INC?
PGNY does not pay a dividend.
What is the ChartMill rating of PROGYNY INC stock?
PGNY has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
Where is PROGYNY INC (PGNY) stock traded?
PGNY stock is listed on the Nasdaq exchange.
What is the GICS sector and industry of PGNY stock?
PROGYNY INC (PGNY) operates in the Health Care sector and the Health Care Providers & Services industry.
What is the employee count for PGNY stock?
PROGYNY INC (PGNY) currently has 856 employees.